Association of a Crime Prevention Program for Boys With Mortality 72 Years After the Intervention Follow-up of a Randomized Clinical Trial

被引:15
|
作者
Welsh, Brandon C. [1 ]
Zane, Steven N. [2 ]
Zimmerman, Gregory M. [1 ]
Yohros, Alexis [1 ]
机构
[1] Northeastern Univ, Sch Criminol & Criminal Justice, Churchill Hall,360 Huntington Ave, Boston, MA 02115 USA
[2] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA
关键词
DISRUPTIVE BOYS; DELINQUENCY; CHILDREN; VIOLENCE; IMPACT; DEATH; HARM;
D O I
10.1001/jamanetworkopen.2019.0782
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Mortality is an important outcome in evaluating crime prevention programs, but little is known about the effects on mortality during the full life course. OBJECTIVE To determine the long-term outcomes of a crime prevention program on mortality and whether the iatrogenic effects on mortality observed in middle age persist or change in old age. DESIGN This longitudinal follow-up was conducted in a cohort of boys included in a matched-pair randomized clinical trial (the Cambridge-Somerville Youth Study). Six hundred fifty boys aged 5 to 13 years who lived and attended public and parochial schools in working-class areas of Cambridge and Somerville, Massachusetts, and were identified as at risk for antisocial behavior were matched by age and demographic characteristics. One member of each pair was randomly allocated to the treatment condition. The original trial was performed from June 1, 1939, to December 1945. Follow-up in the present analysis was performed from January 2016 through June 2018. INTERVENTIONS Treatment group participants received individual counseling through a range of activities and home visits for an extended duration (mean, 5.5 years). Control group participants received no special services. MAIN OUTCOMES AND MEASURES The 4 outcomes of interest include age at mortality, mortality at latest follow-up, premature mortality (younger than 40 years), and cause of mortality (natural vs unnatural). RESULTS In the original analysis, 650 participants were matched and randomized to treatment or control conditions, of whom 506 were retained in the analysis (mean [SD] age, 9.8 [1.7] years). Through early 2018, records for 488 participants (96.4%) were located. A total of 446 participants were confirmed dead (88.1%) and 42 alive (8.3%). Matched-pairs analyses showed no significant differences between the treatment and control groups for mortality at latest follow-up (relative risk [RR], 1.05; 95% CI, 0.99-1.11), premature mortality (RR, 1.15; 95% CI, 0.55-2.43), or cause of mortality (RR, 1.19; 95% CI, 0.65-2.18) (P>.05 for all). Cox proportional hazard regression indicated no difference in time to death between groups (hazard ratio, 1.18; 95% CI, 0.98-1.41; P=.09). CONCLUSIONS AND RELEVANCE Iatrogenic effects on mortality were not detected in this long-term follow-up. The longitudinal analysis provides information on the utility of life-long assessments of crime prevention programs and draws attention to the need for quality-of-life assessments of participants and their children.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] The Randomized Linxian Dysplasia Nutrition Intervention Trial After 26 Years of Follow-up: No Effect of Multivitamin Supplementation on Mortality
    Wang, Jian-Bing
    Abnet, Christian C.
    Fan, Jin-Hu
    Qiao, You-Lin
    Taylor, Philip R.
    JAMA INTERNAL MEDICINE, 2013, 173 (13) : 1259 - 1261
  • [2] Follow-up of a healthy lifestyle education program (the EdAl study): four years after cessation of randomized controlled trial intervention
    Elisabet Llauradó
    Lucia Tarro
    David Moriña
    Magaly Aceves-Martins
    Montse Giralt
    Rosa Solà
    BMC Public Health, 18
  • [3] Follow-up of a healthy lifestyle education program (the EdAl study): four years after cessation of randomized controlled trial intervention
    Llaurado, Elisabet
    Tarro, Lucia
    Morina, David
    Aceves-Martins, Magaly
    Giralt, Montse
    Sola, Rosa
    BMC PUBLIC HEALTH, 2018, 18 : 104
  • [4] Effect of a Transitional Care Intervention on Rehospitalization and Mortality after Sepsis: A 12-Month Follow-up of a Randomized Clinical Trial
    Kowalkowski, Marc A.
    Rios, Aleta
    McSweeney, Joan
    Murphy, Stephanie
    McWilliams, Andrew
    Chou, Shih-Hsiung
    Hetherington, Timothy
    Rossman, Whitney
    Taylor, Stephanie P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (06) : 783 - 786
  • [5] Intervention to Improve Follow-Up for Abnormal Papanicolaou Tests: A Randomized Clinical Trial
    Breitkopf, Carmen Radecki
    Dawson, Lauren
    Grady, James J.
    Breitkopf, Daniel M.
    Nelson-Becker, Carolyn
    Snyder, Russell R.
    HEALTH PSYCHOLOGY, 2014, 33 (04) : 307 - 316
  • [6] Extended follow-up of a randomized controlled trial of the Lidcombe Program of Early Stuttering Intervention
    Jones, Mark
    Onslow, Mark
    Packman, Ann
    O'Brian, Sue
    Hearne, Anna
    Williams, Shelley
    Ormond, Tika
    Schwarz, Ilsa
    INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS, 2008, 43 (06) : 649 - 661
  • [7] Infections in the ustekinumab psoriasis clinical trial program: Final report with up to 5 years of follow-up
    Strober, Bruce
    Lebwohl, Mark
    Ghislain, P. D.
    Szapary, Philippe
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB203 - AB203
  • [8] Infection rates in the ustekinumab psoriasis clinical trial program: Update with up to 4 years of follow-up
    Kimball, A. B.
    Menter, A.
    Reich, K.
    Szapary, P. O.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB195 - AB195
  • [9] Infection rates in the Ustekinumab psoriasis clinical trial program: Update with up to 4 years of follow-up
    Kimball, A. B.
    Bissonnette, R.
    Leonardi, C.
    Menter, A.
    Szapary, P. O.
    Wasfi, Y.
    Ott, E.
    Hsu, M.
    van de Kerkhof, P.
    Reich, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 : 52 - 52
  • [10] Comparison of As-Needed and Scheduled Posthospitalization Follow-up for Children Hospitalized for Bronchiolitis The Bronchiolitis Follow-up Intervention Trial (BeneFIT) Randomized Clinical Trial
    Coon, Eric R.
    Destino, Lauren A.
    Greene, Tom H.
    Vukin, Elizabeth
    Stoddard, Greg
    Schroeder, Alan R.
    JAMA PEDIATRICS, 2020, 174 (09)